Singapore markets closed

Danimer Scientific, Inc. (DNMR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
1.0100-0.0500 (-4.72%)
At close: 04:00PM EST
1.0100 0.00 (0.00%)
After hours: 07:50PM EST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-144,090
-179,758
-60,107
-12,573
-19,514
Depreciation & amortisation
28,911
20,086
10,634
5,123
4,069
Deferred income taxes
-246
-814
-13,233
0
4,137
Stock-based compensation
56,787
56,958
55,270
3,645
5,271
Change in working capital
13,959
-19,321
-28,874
-7,181
8,684
Accounts receivable
3,053
-3,056
-10,835
-1,600
2,195
Inventory
8,576
-11,170
-9,799
-6,604
-2,993
Accounts payable
1,016
-1,565
2,048
993
3,635
Other working capital
-92,162
-226,323
-248,374
-52,065
-38,233
Other non-cash items
7,773
2,267
2,808
2,464
1,511
Net cash provided by operating activities
-35,586
-61,837
-62,963
-13,797
-1,673
Cash flows from investing activities
Investments in property, plant and equipment
-56,576
-164,486
-185,411
-38,268
-36,560
Acquisitions, net
0
-14
-151,179
-
0
Other investing activities
-
-18,037
-
-
-13,408
Net cash used for investing activities
-56,558
-182,482
-336,168
-38,259
-49,093
Cash flows from financing activities
Debt repayment
-13,055
-1,504
-27,162
-1,941
-15,222
Common stock issued
-
-
-
32,518
8,752
Common stock repurchased
-
-236
-890
0
-4,602
Other financing activities
-33,555
-1,800
-47,192
382,011
16,319
Net cash used provided by (used for) financing activities
83,208
21,752
306,202
422,675
53,498
Net change in cash
-8,936
-222,567
-92,929
370,619
2,732
Cash at beginning of period
100,790
286,968
379,897
9,278
6,546
Cash at end of period
91,854
64,401
286,968
379,897
9,278
Free cash flow
Operating cash flow
-35,586
-61,837
-62,963
-13,797
-1,673
Capital expenditure
-56,576
-164,486
-185,411
-38,268
-36,560
Free cash flow
-92,162
-226,323
-248,374
-52,065
-38,233